129 related articles for article (PubMed ID: 34798395)
21. Predictors of prostate cancer on repeat prostatic biopsy in men with serum total prostate-specific antigen between 4.1 and 10 ng/mL.
Okegawa T; Kinjo M; Ohta M; Miura I; Horie S; Nutahara K; Higashihara E
Int J Urol; 2003 Apr; 10(4):201-6. PubMed ID: 12657099
[TBL] [Abstract][Full Text] [Related]
22. Molecular forms of prostate-specific antigen in malignant and benign prostatic tissue: biochemical and diagnostic implications.
Jung K; Brux B; Lein M; Rudolph B; Kristiansen G; Hauptmann S; Schnorr D; Loening SA; Sinha P
Clin Chem; 2000 Jan; 46(1):47-54. PubMed ID: 10620571
[TBL] [Abstract][Full Text] [Related]
23. Human glandular kallikrein as a tool to improve discrimination of poorly differentiated and non-organ-confined prostate cancer compared with prostate-specific antigen.
Recker F; Kwiatkowski MK; Piironen T; Pettersson K; Huber A; Lümmen G; Tscholl R
Urology; 2000 Apr; 55(4):481-5. PubMed ID: 10736487
[TBL] [Abstract][Full Text] [Related]
24. [The application of complexed PSA and its relative indexes in the diagnosis of prostate cancer].
Chen ZH; Zhao J; Wu JM; Xiao CG
Zhonghua Nan Ke Xue; 2003 Feb; 9(1):36-9. PubMed ID: 12680329
[TBL] [Abstract][Full Text] [Related]
25. Effect of histological inflammation on total and free serum prostate-specific antigen values in patients without clinically detectable prostate cancer.
Stimac G; Spajic B; Reljic A; Katusic J; Popovic A; Grubisic I; Tomas D
Korean J Urol; 2014 Aug; 55(8):527-32. PubMed ID: 25132947
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic accuracy of percent free prostate-specific antigen in prostatic pathology and its usefulness in monitoring prostatic cancer patients.
Minardi D; Galosi AB; Recchioni A; Giammarco L; Polito M; Muzzonigro G
Urol Int; 2001; 67(4):272-82. PubMed ID: 11741128
[TBL] [Abstract][Full Text] [Related]
27. Total PSA, free PSA/total PSA ratio, and molecular PSA detection in prostate cancer: which is clinically effective and when?
Basso D; Fogar P; Piva MG; Navaglia F; Mazza S; Prayer-Galetti T; Castellucci E; Pagano F; Plebani M
Urology; 2000 May; 55(5):710-5. PubMed ID: 10792086
[TBL] [Abstract][Full Text] [Related]
28. Comparison of two investigative assays for the complexed prostate-specific antigen in total prostate-specific antigen between 4.1 and 10.0 ng/mL.
Okegawa T; Noda H; Nutahara K; Higashihara E
Urology; 2000 May; 55(5):700-4. PubMed ID: 10792084
[TBL] [Abstract][Full Text] [Related]
29. [Aggressiveness and extent of prostatic inflammation relates with serum PSA levels in type IV prostatitis].
Man LB; Li GZ; Huang GL; Wang JW; Liu BY
Zhonghua Nan Ke Xue; 2012 Aug; 18(8):710-4. PubMed ID: 22934516
[TBL] [Abstract][Full Text] [Related]
30. Proximity ligation measurement of the complex between prostate specific antigen and alpha1-protease inhibitor.
Zhu L; Koistinen H; Landegren U; Stenman UH
Clin Chem; 2009 Sep; 55(9):1665-71. PubMed ID: 19643837
[TBL] [Abstract][Full Text] [Related]
31. Discrimination of prostate cancer from benign disease by plasma measurement of intact, free prostate-specific antigen lacking an internal cleavage site at Lys145-Lys146.
Nurmikko P; Pettersson K; Piironen T; Hugosson J; Lilja H
Clin Chem; 2001 Aug; 47(8):1415-23. PubMed ID: 11468231
[TBL] [Abstract][Full Text] [Related]
32. Analysis of subforms of free prostate-specific antigen in serum by two-dimensional gel electrophoresis: potential to improve diagnosis of prostate cancer.
Jung K; Reiche J; Boehme A; Stephan C; Loening SA; Schnorr D; Hoesel W; Sinha P
Clin Chem; 2004 Dec; 50(12):2292-301. PubMed ID: 15472031
[TBL] [Abstract][Full Text] [Related]
33. The stability of free and bound prostate-specific antigen.
Cartledge JJ; Thompson D; Verril H; Clarkson P; Eardley I
BJU Int; 1999 Nov; 84(7):810-4. PubMed ID: 10532977
[TBL] [Abstract][Full Text] [Related]
34. Analytical performance of the VITROS® Immunodiagnostic Products total PSA II and free PSA assays.
De Keukeleire S; Wauters A; Luyts D; Chandler C; Piqueur M
Clin Biochem; 2014 Sep; 47(13-14):1323-5. PubMed ID: 24940637
[TBL] [Abstract][Full Text] [Related]
35. Influence of free-to-total prostate specific antigen variability on the early diagnosis of prostate cancer: a comparative study of three immunoassays.
de la Taille A; Houlgatte A; Houdelette P; Goluboff ET; Berlizot P; Ricordel I
Br J Urol; 1998 Sep; 82(3):389-92. PubMed ID: 9772876
[TBL] [Abstract][Full Text] [Related]
36. Comparison of 6 automated assays for total and free prostate-specific antigen with special reference to their reactivity toward the WHO 96/670 reference preparation.
Kort SA; Martens F; Vanpoucke H; van Duijnhoven HL; Blankenstein MA
Clin Chem; 2006 Aug; 52(8):1568-74. PubMed ID: 16762996
[TBL] [Abstract][Full Text] [Related]
37. The ratio of prostate-specific antigen (PSA) to prostate volume (PSA density) as a parameter to improve the detection of prostate carcinoma in PSA values in the range of < 4 ng/mL.
Stephan C; Stroebel G; Heinau M; Lenz A; Roemer A; Lein M; Schnorr D; Loening SA; Jung K
Cancer; 2005 Sep; 104(5):993-1003. PubMed ID: 16007682
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the clinical performance of equimolar- and skewed-response total prostate-specific antigen assays versus complexed and free PSA assays and their ratios in discriminating between benign prostatic hyperplasia and prostate cancer.
Wians FH; Cheli CD; Balko JA; Bruzek DJ; Chan DW; Sokoll LJ
Clin Chim Acta; 2002 Dec; 326(1-2):81-95. PubMed ID: 12417099
[TBL] [Abstract][Full Text] [Related]
39. A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy.
Auprich M; Augustin H; Budäus L; Kluth L; Mannweiler S; Shariat SF; Fisch M; Graefen M; Pummer K; Chun FK
BJU Int; 2012 Jun; 109(11):1627-35. PubMed ID: 21939492
[TBL] [Abstract][Full Text] [Related]
40. Impact of chronic dialysis on serum PSA, free PSA, and free/total PSA ratio: is prostate cancer detection compromised in patients receiving long-term dialysis?
Djavan B; Shariat S; Ghawidel K; Güven-Marberger K; Remzi M; Kovarik J; Hoerl WH; Marberger M
Urology; 1999 Jun; 53(6):1169-74. PubMed ID: 10367847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
